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Abdominal aortic aneurysm (AAA) is a common age-related vascular disease characterized
by progressive weakening and dilatation of the aortic wall. Thrombospondin-1 (TSP-1; gene
Thbs1) is a member of the matricellular protein family important in the control of extracellular
matrix (ECM) remodelling. In the present study, the association of serum TSP-1 concentra-
tion with AAA progression was assessed in 276 men that underwent repeated ultrasound
for a median 5.5 years. AAA growth was negatively correlated with serum TSP-1 concen-
tration (Spearman’s rho −0.129, P=0.033). Men with TSP-1 in the highest quartile had a
reduced likelihood of AAA growth greater than median during follow-up (OR: 0.40; 95%
confidence interval (CI): 0.19–0.84, P=0.016, adjusted for other risk factors). Immunohisto-
chemical staining for TSP-1 was reduced in AAA body tissues compared with the relatively
normal AAA neck. To further assess the role of TSP-1 in AAA initiation and progression,
combined TSP-1 and apolipoprotein deficient (Thbs1−/−ApoE−/−, n=20) and control mice
(ApoE−/−, n=20) were infused subcutaneously with angiotensin II (AngII) for 28 days. Follow-
ing AngII infusion, Thbs1−/− ApoE−/− mice had larger AAAs by ultrasound (P=0.024) and
ex vivo morphometry measurement (P=0.006). The Thbs1−/−ApoE−/− mice also showed
increased elastin filament degradation along with elevated systemic levels and aortic ex-
pression of matrix metalloproteinase (MMP)-9. Suprarenal aortic segments and vascular
smooth muscle cells (VSMCs) isolated from Thbs1−/−ApoE−/− mice showed reduced colla-
gen 3A1 gene expression. Furthermore, Thbs1−/−ApoE−/− mice had reduced aortic expres-
sion of low-density lipoprotein (LDL) receptor-related protein 1. Collectively, findings from
the present study suggest that TSP-1 deficiency promotes maladaptive remodelling of the
ECM leading to accelerated AAA progression.
Introduction
Abdominal aortic aneurysm (AAA) is an important cause of death in older adults due to aortic rupture
[1,2]. AAA screening programmes have been introduced in North America, the United Kingdom and
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parts of Europe [3]. There has also been an enormous increase in the use of abdominal imaging in most parts of the
developed world [4]. As a result in many parts of the world, AAAs are now identified at an early stage when they
are small and at a low risk of rupture. Previous randomized trials suggest that asymptomatic small AAAs measuring
<55mm should not be treated by surgical repair but rather be monitored by imaging surveillance until they grow to
55mm or become symptomatic [5–8]. However, most small AAAs continue to grow and eventually require surgical
repair. Effective medical treatments are needed to limit AAA growth, rupture and requirement for AAA surgery
[5–10].
Examination of AAA biopsies from humans and experimental models suggest that chronic aortic wall inflamma-
tion and extracellular matrix (ECM) remodelling are important in AAA pathogenesis [1,2]. The thrombospondins
(TSPs), are a family of glycoproteins secreted by platelets, macrophages, vascular smooth muscle cells (VSMCs), en-
dothelial cells and fibroblasts [11]. TSP-1 (encoded by the THBS1 gene) is an endogenous inhibitor of angiogenesis,
regulates cell proliferation and plays a crucial role in inflammation [12,13]. TSP-1 modulates VSMC and fibroblast
phenotype and preserves the ECM by inhibiting matrix metalloproteinase (MMP) activity [14,15]. TSP-1 interacts
with multiple receptors in different cell types and diverse, and at times, paradoxical effects of TSP-1 have been re-
ported [11].
A large body of in vitro and in vivo data suggests that TSP-1 plays an important role in vascular remodelling by
regulating the arterial response to injury [12,16–22]. We previously reported that serum TSP-1 levels were negatively
associated with human AAA diagnosis suggesting a possible protective role of TSP-1 against AAA [23]. In support of
this theory, we recently reported that a peptide that antagonizes the ability of TSP-1 to activate transforming growth
factor β (Tgf-β), promoted AAA growth in an apolipoprotein E (ApoE) deficient (ApoE−/−) mouse model in which
AAA was induced by angiotensin (Ang) II infusion [24]. Furthermore, TGF-β neutralization with either a rabbit
or mouse TGF-β neutralizing antibody enhances AngII-induced aortic rupture and aneurysm formation [25]. In
contrast, deficiency of Thbs1 in C57BL/6 mice (TSP-1 deficient (Thbs1−/−)) has been reported to result in pro-
tection from AAA induction by peri-aortic application of calcium phosphate (CaPO4) or infusion of elastase [26].
C57BL/6mice lack concurrent atherosclerosis, which is a usual feature of human AAA [27]. The concurrent presence
of atherosclerosis maybe important since TSP-1 has been previously reported to modify atherosclerosis-associated
inflammation [28,29]. Given the disparate previous findings regarding the role of TSP-1 in AAA, we performed a
combined human and rodent model study to further investigate this. Firstly, we assessed the association of serum
TSP-1 concentrations with human AAA growth. Secondly, we assessed the effect of TSP-1 deficiency on abdominal




Sera from participants of the Health In Men Study (HIMS) [30], were used to assess circulating concentrations of
TSP-1. Entry criteria included the following: (i) an AAA (defined as maximum aortic diameter30mm); (ii) a min-
imum of 3 years ultrasound surveillance and (iii) clinical data and blood samples were available [31,32]. Collection
of detailed medical history, clinical examination and blood analysis were carried out on all patients. Identification
of cardiovascular risk factors including hypertension, dyslipidaemia, smoking history, diabetes and coronary heart
disease (CHD) was as previously defined [33]. The characteristics of the included men are shown in Supplementary
Table S1.
Arterial biopsies were obtained from subjects undergoing open surgical AAA repair at The Townsville Hospital,
Queensland, Australia. Samples collected from the AAA included full thickness biopsies from the anterior wall of
the body (site of maximum aortic dilation) and macroscopically non-dilated proximal neck (site immediately distal
to the renal arteries where the aortic diameter was relatively normal). Our previous study suggested that AAA neck
samples have a relatively normal morphology with the aortic structure preserved along with minimal inflammation
[34]. Paired AAA body and neck biopsies were collected from six patients and a piece of tissue was stored in optimal
cutting compound (OCT, ProSciTech) at −80◦C for immunohistochemistry (IHC). Approval was obtained from the
relevant ethics committees, informed patients’ consents were obtained and the study conformed to the guidelines of
the Declaration of Helsinki.
Measurement of aortic diameter in patients
AAA growth was assessed using ultrasound-based assessment as reported previously [35].Maximum anteroposterior
and transverse infrarenal aortic diameter were measured by experienced sonographers. Repeated aortic imaging was
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performed at the discretion of the local clinician. In general, repeated scans were carried out yearly for 30–44 mm
AAAs and every 6months for 45–50mmAAAs. Aortic diameter wasmeasured from the outer wall to the outer wall of
the artery. The reproducibility of aortic diametermeasurementswere regularly assessed, with between observer repro-
ducibility coefficients being consistently<4 mm, which we had reported previously [32]. Previous reports published
from the group show the reproducibility of the aortic diametermeasurements [32,36]. Briefly, to assess intra-rater and
inter-rater differences in aortic diameter measurements, ten subjects were selected at intervals of 4months during the
initial screening period and in the follow-up study, at random for assessments. Each man was scanned twice by each
observer as well as by a senior vascular sonographer. All scans were performed with the operators blinded to previous
aortic diameter measurements. No significant differences were found between observers, with 95% of differences in
each of anteroposterior and transverse diameters being<3 mm [32].
AAA induction in mice
ApoE−/− mice were obtained from the Animal Resources Centre, Canning Vale, Western Australia.
Thbs1−/−ApoE−/− mice were sourced from the breeding programme of Prof William A. Frazier, Washington
University School of Medicine, U.S.A. All animals were housed in the James Cook University (JCU) animal facility
with free access to food and water. The temperature in the animal facility was 23 +− 2◦C and the relative humidity
was 55 +− 2%, with a 12 h dark/light cycle. All animal protocols conformed to the Guide for the Care and use of
Laboratory Animals by the United States National Institutes of Health and the Australian Code of Practice for the
Care and Use of Animals for Scientific Purpose (seventh edition, 2004). Ethical approval was obtained from the local
institutional committee prior to commencement of the study.
Twelve-weeks-old male ApoE−/− (n=20) and Thbs1−/−ApoE−/− mice (n=20) were anaesthetized by intraperi-
toneal (i.p.) injection of ketamine (150 mg/kg) and xylazine (10 mg/kg) and miniosmotic pumps (model 2004,
ALZET) delivering 1 μg/kg per min of angiotensin II (AngII, Sigma–Aldrich) were placed subcutaneously as re-
ported previously to administer over 28 days [37–39]. Blood was collected at different time points (baseline, day 14
and 28) into EDTA tubes (BD Vacutainer) to separate platelet-poor plasma. At the end of experiments (14 or 28 days
AngII infusion), the mice were killed by CO2 and blood was collected by cardiac puncture.
Measurement of aortic diameters in mice
Mice were monitored every week by ultrasound sonography using a MyLab 70 VETXV platform (Esaote, Genoa) in
B-mode with an LA435 linear transducer (Esaote, Genoa) at an operating frequency of 10 MHz (LA435; Esaote) to
provide a sagittal image of the aorta as reported previously [38,40]. Imagingwas performed on a constant-temperature
table usingwarm acoustic coupling gel.Maximum suprarenal aortic luminal diameter wasmeasured at peak systole in
sagittal images in anterior to posterior plane from the inner to inner aortic wall, using calipermeasurements following
protocols as previously described by our group [38,39,41].We have previously demonstrated that ultrasound diameter
measurements have good interobserver reproducibility [38,39].
At necropsy, aortas were carefully cleared of peri-aortic fat deposits and perfused with PBS under physiological
pressure. Aortas were harvested from mice completing the study protocol or that died during the study. The aortas
were excised and placed on a graduated template and digitally photographed (Coolpix 4500, Nikon). The maximum
ex vivo external aortic diameters of the aortic arch, thoracic aorta (TA), the suprarenal abdominal aorta (suprarenal
aorta (SRA)) and the infrarenal aorta (IRA) weremeasured as previously reported [38,41,42] using Adobe Photoshop
software (CS6). Representative portions of aortic segments were dissected and stored in either optimal cutting com-
pound (OCT, ProSciTech) compound or RNA later (Qiagen) for subsequent experiments. Necropsy was performed
within 24 h of sudden mouse fatality to confirm aortic rupture as the cause of death.
Non-invasive tail-cuff blood pressure measurements
Tail-cuff measurement of systolic blood pressure (SBP) and heart rate were measured in conscious mice with a
non-invasive tail-cuff system (CODA monitor, Kent Scientific, U.S.A.). All animals were acclimatized to the device
2 days before measuring the blood pressure as previously established [42]. All mice were allowed to acclimatize to
the restrainer chamber on a warm pad for 10 min in a temperature-controlled room before the measurements and
multiplemeasurements were recorded at each time point, i.e. at baseline (day 0), day 14 and 28 during AngII infusion.
Blood pressure and heart rate were measured repeatedly and the measurements were averaged from ten consecutive
measurements. Good reproducibility of this technique has been previously established [39,41,42].
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Serum and plasma analysis
Sera from AAA patients were assayed to measure creatinine, low-density lipoprotein (LDL), high-density lipopro-
tein (HDL) and total homocysteine using automated enzymatic assays as previously described [43–45]. Serum high
sensitivity C-reactive protein (CRP) concentration was measured by immunophelometry using the BNII analyzer
as reported previously (Dade Behring, Milton Keynes, U.K.) [32]. Serum TSP-1, MMP-9, TGF-β1 and plasma
interleukin-6 (IL-6) concentrations were measured using previously validated ELISAs according to the manufac-
turer’s instructions (Duoset R©; R&D Systems, Minneapolis, Minnesota, U.S.A.) [46].
For themouse study, platelet-poor plasmawere prepared from blood samples taken at the beginning of the study by
tail bleeding and end of the study by cardiac puncture. Briefly, platelet-poor plasma was separated by centrifugation
of blood at 2000×g at 4◦C for 10 min followed by further 10 min centrifugation at 15000×g at 4◦C. The plasma
samples were snap-frozen in liquid nitrogen and stored at −80◦C for subsequent assessments. A multiple analyte
mouse inflammation cytometric bead array (CBA, BD Biosciences) was used to quantificatively measure plasma
levels of IL-6, IL-10, monocyte chemoattractant protein-1 (MCP-1), interferon-γ (IFN-γ), tumour necrosis factor
(TNF) and IL-12p70. Flow cytometry was performed on a CyAn ADP flow cytometer (Beckman Coulter) and CBA
data were analysed with FCAP Array software (BD Biosciences), following manufacturer’s instructions. Circulating
levels of total and activemouse Tgf-β1 (R&D systems) and levels ofMMP-9 (R&D systems) were quantified in plasma
samples using a commercially available assay according to the manufacturer’s instructions. Total nitrate and nitrite
(nitric oxide metabolites) were measured in plasma samples by a Nitrate/Nitrite Colorimetric Assay Kit following
the manufacturer’s protocol (Cayman). Briefly, nitrate was converted into nitrite using nitrate reductase. Subsequent
addition of Griess reagents converted nitrite into a deep purple azo compound and the absorbance was measured at
540 nm using an Omega plate reader. We have previously reported this assay to be reproducible [40,42].
Quantification of atherosclerotic lesion area
Presence of aneurysm in the abdominal aorta permitted analysis of atherosclerosis lesions only in the aortic arch,
defined as the region from the ascending aorta to 3 mm distal to the subclavian artery. The en face Sudan IV staining
method is widely used to assess atherosclerotic deposits on the intimal surface [47]. Sudan IV staining was performed
in aortic arch segments to assess the atherosclerotic lesion area. The degree of atherosclerosis was quantified and
expressed as a percentage of the total luminal surface area following methods described previously. We have shown
in multiple studies that this method is highly reproducible [48].
Histopathology
SRA segments stored inOCT (ProSciTech) fromeachmice groupwere selected using a randomnumber generator and
cut into 6-μm-thick sections. The adjacent sectionswere stainedwith haematoxylin and eosin (H&E, ProSciTech) and
mounted in Entellan mounting medium (ElectronMicroscopy Sciences, U.S.A.). Aortic sections were also processed
for Elastin Van Gieson (EVG) staining (Polysciences, Inc) for elastin and Picrosirius staining (Polysciences, Inc) for
collagen. The stained H&E and EVG sections were photographed using a Nikon Eclipse 50i microscope fitted with a
CCD camera (DSFi1) and digital images captured into a PC supported with NIS Elements (version F2.30).
Elastin filament fragmentation in each field was recorded under 40× magnification from two to three aorta sec-
tions from eachmouse. Elastin fragmentationwas graded for quantitative evaluation as reported previously according
to the following criteria: 1–no elastin breaks, 2–mild fragmentation, 3–moderate to severe and 4–severe elastin fila-
ment fragmentation.We have shown previously that this grading method is highly reproducible [49,50]. Images were
obtained under polarizationmicroscope (Zeiss AxioVision) to assess collagen content and expressed as percentage of
stained area of the total section area under bright field. Sections were photographed with identical exposure setting
for each section. The percentage of birefringence was determined for four to five fields of at least three sections from
each mouse (n=6/group), and the mean value was calculated for each region as described previously [24].
To localize cells undergoing nuclear DNA fragmentation, in situ terminal deoxynucleotidyl transferase (TdT) me-
diated dUTP nick-end labelling (TUNEL) was performed using an in situ apoptosis kit specially developed for vas-
cular tissues (VasoTACS, Trevigen). The cryostat sections (6μm) were processed for the TUNEL assay as described
previously [50,51] and both positive and negative control slides were processed at the same time (n=6). The presence
of apoptotic cells was identified as dark nuclear staining with the distinctive morphological appearance associated
with cell shrinkage and chromatin condensation (apoptotic cells) or cytoplasmic fragments with or without con-
densed chromatin (apoptotic bodies). The images were captured at 400× magnification, and percentage of positive
staining area was calculated by dividing the positive staining area by the total area of the region selected. For each
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region of interest, a spot check was performed by visually counting the cells and avoiding necrotic areas. All histolog-
ical evaluations were done in a blinded fashion in at least three to four sections per sample (intra-assay coefficient of
variation =2.97%, n=5 [50]).
IHC
Aneurysmal and adjacent non-aneurysmal human aortic samples were obtained during surgery from six patients
undergoing AAA repair. Removal of these tissues was accomplished as a part of the normal operative procedure, in
which both aneurysm and adjacent non-aneurysmal segments were trimmed in preparation for graft anastomosis
and stored in OCT compound. Serial cryostat sections (6 μM) were cut from each tissue sample on to silane-coated
slides (ProSciTech). The sections were air dried, fixed in acetone for 10 min at −20◦C, air dried and processed for
IHC as described previously [24]. Human aortic sample sections were stained with a TSP-1 antibody (1:200; Santa
Cruz Biotechnology, U.S.A.).
Randomly selected ApoE−/− andThbs1−/−ApoE−/− suprarenal aortic segments were stored in OCT compound
(ProSciTech). Serial cryostat sections (6μM)were cut from each tissue sample on to silane-coated slides (ProSciTech)
and sections were air dried, fixed in acetone for 10 min at−20◦C, air dried and processed for IHC as described previ-
ously [38]. Briefly, the sections were rehydrated with PBS before being incubated in 3%H2O2/0.1% sodium azide/PBS
to block endogenous peroxidase. Slides were then incubated in 2% normal goat serum (Vector Laboratories) in PBS
and endogenous avidin and biotin blocked using Avidin/Biotin Blocking Kit (Vector Laboratories), then incubated
with primary antibody anti-monocyte and macrophage antibody (MOMA-2, 1:500; ab33451) overnight at 4◦C. The
secondary antibody used was biotinylated anti-rat IgG (BA-9400, 1:500 dilution, Vector). Slides were incubated in the
peroxidase substrate 3,3′-diamminobenzidine (ImmPACT DAB, Vector), counterstained in Mayer’s Haematoxylin,
dehydrated, cleared in xylene and mounted in Entellan mounting medium (Electron Microscopy Sciences). Sections
were stained simultaneously, using identical reagents and incubation times. Specimens incubated with non-relevant
isotype-matched monoclonal negative controls for animal studies and no primary antibody for human specimens
served as negative controls. Digital images of the stained sections were photographed using the Nikon microscope
(Nikon Eclipse 50i) as mentioned in the previous section and staining was quantified by image analysis. Image anal-
ysis was performed on digital-tiff images captured into a PC supported with image analysis software (NIS Elements,
version F2.30) and quantified as described previously by our group [38,39].
In situ zymography
Cryostat sections (6 μM) obtained from suprarenal aortic segments embedded in OCT underwent in situ zymogra-
phy using MMP fluorogenic substrate DQ–gelatin–FITC (20 μg/ml, Invitrogen). In brief, frozen aortic tissues were
pre-incubated in water at 37◦C for 40 min, and then overlaid with a fluorogenic substrate DQ gelatin (20 μg/ml, In-
vitrogen) diluted 1:100 in the buffer supplied by themanufacturer, for 40min at 37◦C. The sections were washed with
PBS and fixed in 4% paraformaldehyde (PFA, Sigma), at room temperature for 15min. The sections were washed and
allowed to dry prior to placement of a coverslip (Vector Labs). The signal was observed through an immunofluores-
centmicroscope (Zeiss AxioVision) and the proteolytic activity (combined gelatinase activity ofMMP-2 andMMP-9)
was detected as bright green fluorescence (530 nm). The specificity of the reactions was examined using global chem-
ical MMP inhibitors 1, 10-phenanthroline (20 mm/l, Molecular Probes), and EDTA (10 mmol/l) was used to define
non-specific fluorescence. Digital images were analysed in a blinded manner and presented as percentage area show-
ing gelatinase activity in relation to the total area of the section selected.
Confocal microscopy
Whole thickness suprarenal aortic biopsies from saline infused ApoE−/− (n=3) and AngII-infused ApoE−/− mice
(n=3), were fixed and processed for confocal microscopy as previously described [52]. Tissues were probed with
rabbit anti-LDL receptor-related protein 1 (LRP1, 1:200, ab92544) overnight at 4◦C, followed by goat anti-rabbit
Alexa Fluor R© 568 and phalloidin Alexa Fluor R© 488 (Life Technologies) for 2 h at room temperature. A Zeiss LSM
710 inverted confocal microscope was used to image sections with a 10× lens (0.4 NA) and 63× (1.4 NA) lens with
the pinhole set to 1 airy unit. The lasers had wave length of 488 and 568 nm and the pixel resolution was 0.28 μm per
pixel for 10× lens and 0.082 μm per pixel for 63× lens.
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Isolation of VSMCs
Primary VSMCs were isolated from the aortas of 8–12-week-old male Thbs1−/−ApoE−/− (n=6) and littermate
ApoE−/− mice (n=6), subjected to subcutaneous infusion of AngII for 14 days as mentioned in the previous sec-
tion. All mice were anaesthetized with a mixture of ketamine/xylazine (100 and 10 mg/kg body weight respectively)
and killed by CO2 asphyxiation. Briefly, adhering fat and connective tissue were removed by blunt dissection from the
aorta. The aorta was harvested under dissection microscope magnification, and placed in ice-cold culture medium
(DMEM with 10% FBS, 100 U/ml penicillin, 100 mg/ml streptomycin and 2 mM glutamine; Gibco) [53]. The en-
dothelial layer was denuded with a sterile cotton bud and the adventitia was excised with microsurgical instruments.
The aorta was cut into 1-mm fragments and incubated with 1 mg/ml collagenase type I (Worthington, Lakewood,
NJ) and 0.125mg/ml elastase type III (Worthington, Lakewood, NJ) at 37◦C for 4 h. Cell suspension were centrifuged
at 1500 g for 10 min at 4◦C and cell pellets were resuspended in DMEM containing 10% FBS. The mixture was then
aliquoted into 25 cm2 culture flasks and allowed to grow at 37◦C and 5% CO2 with medium changed every 3 days.
Primary cultures without passages were harvested at day 11 for analysis to minimize contamination with other cell
types.
mRNA analysis by quantitative real-time PCR
Total RNA was isolated from suprarenal aortic segments and VSMCs derived frommice. Eight SRA segments stored
in RNA Later (Qiagen) were selected from each group using random number generators for gene expression analy-
sis by quantitative real-time PCR (qRT-PCR). Total RNA was isolated using an RNeasy Mini kit (Qiagen) according
to manufacturer’s instructions and quantified spectrophotometrically using Nanodrop 2000. Total RNA (20 ng) was
used for qRT-PCR using QuantiTect SYBR Green one-step RT-PCR assay (Qiagen) as per manufacturer’s instruc-
tions. qPCR was performed to evaluate gene expression for the samples using RT2 qPCR Primer Assay for Mouse
(Qiagen) designed for collagen type 1A1 (Col1A1; PPM03845F), collagen type 3A1 (Col3A1; PPM04784B), Lrp1
(PPM05653F), Mmp-9 and glyceraldehyde-3-phosphate dehydrogenase (Gapdh; QT01658692). GAPDH was cho-
sen as the housekeeping gene, since analysis showed its expression to be stable across the samples. PCR reactions
were run in duplicate in the RotorGeneQ (Qiagen). For each gene of interest, the relative expression in each sample
was calculated by using the concentration-Ct-standard curve method and normalized to the average expression of
GAPDH [41].
Western blotting
SRA segments (n=6/group) stored in OCT compound (ProSciTech) were randomly selected using a random number
generator and were homogenized in RIPA buffer (Cell Signaling) in the presence of protease inhibitors (Roche) to
obtain total protein extracts. Protein concentrations were determined using a Bradford Protein Assay Kit follow-
ing manufacturer’s instructions (Bio–Rad). Samples (25 μg of protein per lane) were loaded on to a SDS/PAGE
(10% gel). After electrophoresis (110 V, 90 min), the separated proteins were transferred (15 mA, 60 min) on to a
PVDF membrane (Bio–Rad) and were blocked with 5% non-fat dry milk (5%) that was used for 60 min to block
non-specific sites, and the blots were then incubated with anti-total-Smad2/3 antibody (1:1000, sc-11769; Santa
Cruz Biotechnology), anti-p-Smad2/3 antibody (1:1000, sc-8332; Santa Cruz Biotechnology), anti-total-Akt anti-
body (1:1000, SAB4500797, Sigma–Aldrich) and anti-p-Akt antibody (1:1000, 07-1643; Sigma–Aldrich) overnight at
4◦C. Anti-rabbit HRP–conjugated IgG (1:1000, DakoCytomation) or anti-goat HRP–conjugated IgG (1:1000, Dako-
Cytomation), were used to detect the binding of its corresponding antibody. The protein expression was estimated
with Western Lightning Chemiluminescence Reagent Plus (PerkinElmer Life Sciences) and quantified by Quantity
One software (version 4.6.7, Bio–Rad).
Statistical analysis
The association of TSP-1 with AAA growth (assessed by ultrasound measurements) was analysed using Spearman’s
rho correlation coefficient and multiple logistic regression. Data from mouse studies were analysed using GraphPad
Prism (version 6). Parametric or non-parametric tests were applied appropriate to the distribution of data. Accord-
ingly, aortic end point data for maximum diameter and mRNA expressions were compared using unpaired t test
or Mann–Whitney U test and expressed as mean +− S.E.M. or median and interquartile range (IQR) respectively.
Comparison of data obtained as a function of time was performed using repeated measures two-way ANOVA with
Bonferroni post hoc applied for multiple testing, i.e. blood pressure and ultrasound measurement of the SRA diam-
eter. Categorical data were compared using Fisher’s exact tests. Kaplan–Meier survival curves were analysed using
log-rank (Mantel–Cox) test. In all cases, statistical significance was assumed at P<0.05.
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Figure 1. Serum TSP-1 concentration was negatively correlated with AAA growth and down-regulated in AAA samples
(A) Spearman’s correlation graph showing inverse correlation between average AAA growth and serum TSP1 levels in AAA patients (n=276).
(B) Representative serial cryostat sections of full-thickness human AAA tissues showing H&E staining. The section of the AAA body shows
inflammatory cells and a disrupted medial layer. (C) Representative serial paraffin sections of full-thickness human AAA tissues with im-
munostaining (brown) for TSP-1. The staining for TSP-1 was found to be intense in the biopsy from the proximal AAA neck compared with
weak staining in AAA body section. Low power (×100) photomicrographs. Scale bar =50 μm.
Results
High serum TSP-1 concentration was associated with slower AAA
growth, and expression of TSP-1 was low in samples from the main body
of human AAA
The serum concentration of TSP-1 was assessed in a subset of the participants of the HIMS and details of the men
included in the study are given in the Supplementary Table S1 [30]. Men with AAAs (n=276) measuring a median
(IQR) initial diameter of 32.9 mm (IQR: 31.0–36.1 mm) were followed up for a median of 5.5 years (IQR: 5–6 years)
with amedian of 7 (IQR: 6–7) ultrasound scans.MedianAAA growth asmeasured by ultrasoundwas 1.1mmper year
(IQR: 0.5–1.9) and AAA growth was weakly and negatively correlated with serum TSP-1 concentration (Spearman’s
rho −0.129, P=0.033, n=276) (Figure 1A).
AAA patients were grouped into four quartiles based on the serum levels of TSP-1. Subsequently, men with serum
TSP-1 concentrations in quartiles 2–4were comparedwith subjects who had serumTSP-1 in the lowest quartile. After
adjusting for risk factors previously reported to be associated with AAA growth (including initial AAA diameter,
diabetes, CHD, smoking and statin prescription) men with TSP-1 in the highest quartile had a reduced likelihood
of AAA growth greater than median during follow-up. Men with serum TSP-1 levels in the fourth quartile (>38.36
ng/ml) were less likely to have AAA growth greater thanmedian than those with TSP-1 in the first quartile (OR: 0.40;
95% confidence interval (CI): 0.19–0.84, P=0.016) (Table 1). TSP-1 concentrations were not associated with serum
concentrations of creatinine, HDL, high sensitivity CRP (hs-CRP), homocysteine and plasma IL-6 (Supplementary
Tables S2 and S3). Circulating concentrations of TSP-1 were positively correlated with circulating concentrations of
TGF-β1, MMP-9 and LDL (Supplementary Tables S2 and S3).
To assess the expression of TSP-1 in human AAA samples, we performed IHC using samples taken from the site
of main aortic dilatation (the AAA body) and the relatively non-dilated neck of the AAA. We have previously re-
ported that samples from the AAA neck have relatively preserved aortic structure and minimal inflammation [34].
Histopathological analysis showed that AAA body sections had evidence of marked inflammation and medial layer
destruction, while biopsies of the proximal non-dilated AAA neck showedminimal inflammation and limitedmedial
layer destruction, as previously reported (Figure 1B) [34]. TSP-1 protein expression was relatively down-regulated in
AAA body compared with AAA neck (Figure 1C).
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Table 1 Logistic regression model assessing the association between AAA growth greater than median and serum TSP-1
quartiles
Characteristics OR 95% CI P-value
Serum TSP-1 (ng/ml)*
<26.58 (n=69) 1 Reference group
26.58–31.62 (n=68) 0.72 0.34–1.51 0.378
31.62–38.36 (n=70) 0.50 0.24–1.04 0.063
>38.36 (n= 69) 0.40 0.19–0.84 0.016
Initial AAA diameter >32.9 mm† 3.39 2.01–5.71 <0.001
Statin prescription 1.31 0.77–2.22 0.326
CHD 0.73 0.43–1.26 0.265
Ever-smoker 0.70 0.34–1.43 0.330
Diabetes mellitus 0.24 0.10–0.59 0.002
For nominal variables, the comparisons are to subjects without the risk factor. Staistically significant P-values are show in bold.
*Men with serum TSP-1 concentrations in the top, second and third quartiles were compared with subjects who had serum TSP-1 in the lowest quartile.
†Approximately median value. Abbreviation: n, number.
Table 2 Cardiovascular, biochemical and cellular effects of AngII infusion in ApoE−/− and Thbs1−/− ApoE−/− mice at day 28
Parameters assessed ApoE−/− (n=13) Thbs1−/−ApoE−/− (n=16) P-value
Ultrasound based luminal SRA diameter
(mm)
1.27 +− 0.03 1.42 +− 0.04 0.024
Ex vivo morphometry based external SRA
diameter (mm)
2.32 +− 0.14 3.14 +− 0.24 0.006
Body weight (gm) 29.08 +− 0.47 28.54 +− 0.47 NS
SBP (mmHg) 130.40 +− 1.75 121.20 +− 1.57 0.029
Data expressed as mean +− S.E.M. for normally distributed data and compared by t test or as median and IQRs for non-normally distributed data and
compared by Mann–Whitney U test. Statistical significance considered as P-value <0.05. Abbreviations: n, number; NS, non-significant.
TSP-1 deficiency promoted AngII-induced AAA and atherosclerosis in a
mouse model
To further assess the role of TSP-1 in AAA progression, we used the well-established AngII model of AAA [54]. AngII
was infused in 12-weeks-old male control ApoE−/− (n=20) and experimental Thbs1 and ApoE double-deficient
(Thbs1−/−ApoE−/−; n=20)mice using established protocols. Infusion of AngII for 28 days resulted in aortic ruptures
in both ApoE−/− (deaths=7; 35%) andThbs1−/−ApoE−/− mice (deaths=4; 20%), with no significant difference in
the rupture rate between the two genotypes (P=0.325; Supplementary Figures S1–S3). Aortic diameter was assessed
in vivo using ultrasound to assess the inner wall to the inner wall aortic luminal diameter using sagittal images in the
anterior-posterior plane. AngII infusion for 4 weeks caused a progressive increase in the SRA diameter as assessed
by ultrasound in ApoE−/− andThbs1−/−ApoE−/− mice. The mean maximum (+− S.E.M.) SRA diameter measured
by ultrasound on day 28 of the AngII infusion was 1.27 +− 0.03 and 1.42 +− 0.04 mm in the ApoE−/− control (n=13)
andThbs1−/−ApoE−/− experimental (n=16) mice respectively (P=0.024, Figure 2A, Table 2). These findings were
supported by ex vivo morphometric measurements which showed a similar significantly greater mean maximum (+−
S.E.M.) SRA external (outer wall to outer wall) diameter in Thbs1−/−ApoE−/− (3.14 +− 0.24 mm) compared with
ApoE−/− (2.32 +− 0.14 mm, P=0.006; Figure 2B) mice. Maximum diameters of other aortic regions were similar
between groups (Figure 2B).
En face atherosclerosis assessment was performed by Sudan IV staining of aortic arches. The median (IQR) stain-
ing area was significantly greater in experimentalThbs1−/−ApoE−/− (23.18%, 20.90–38.28) compared with control
ApoE−/− (14.06%, 7.48–33.20, P=0.049; n=8/group; Figure 2D,E) mice.
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Figure 2. TSP-1 deficiency promotes AAA and atherosclerosis in AngII-infused mice
(A) Mean SRA diameter assessed by ultrasound in ApoE−/− (n=13) and Thbs1−/−ApoE−/− (n=16) mice surviving AngII infusion. Data
expressed asmean and S.E.M. and compared by repeatedmeasures two-way ANOVA. (B) Regional maximum diameters of control ApoE−/−
and experimental Thbs1−/−ApoE−/− mice were determined by ex vivomorphometric measurements at the end of 28 days of AngII infusion.
AngII-infused Thbs1−/−ApoE−/− mice had a significantly larger SRA diameter compared with AngII-infused ApoE−/− mice. Data expressed
as median and IQR with maximum and minimum data points (whiskers) and compared by Mann–Whitney U test. (C) Graphs comparing
the effect of AngII infusion on mean SBP in ApoE−/− and Thbs1−/−ApoE−/− mice. Data expressed as mean and S.E.M. and compared by
repeated measures two-way ANOVA. (D) Representative en face Sudan IV stained aortic arches from control ApoE−/− and experimental
Thbs1−/−ApoE−/− mice for quantifying atherosclerosis. (E) Box plots showing that aortic arch Sudan IV staining area was significantly
higher in experimental Thbs1−/−ApoE−/− than control ApoE−/− mice after 28 days of AngII infusion. Data expressed as median and IQR with
maximum and minimum data points (whiskers) for positive staining area relative to total specimen area (%) and compared by Mann–Whitney
U test (n=8/group). Abbreviation: NS, non-significant.
Thbs1−/−ApoE−/− mice had lower blood pressure during AngII infusion
associated with higher circulating concentrations of nitric oxide
metabolites
We compared the systolic blood pressure (SBP) in AngII-infused control ApoE−/− and experimental
Thbs1−/−ApoE−/− mice. Chronic infusion of AngII for 28 days caused a significant time-dependent increase
in mean SBP in both ApoE−/− and Thbs1−/−ApoE−/− mice (Figure 2C). The mean SBP of the experimental
Thbs1−/−ApoE−/− mice and controlApoE−/− mice were similar at baseline, however during the AngII infusion, the
SBP was significantly greater in ApoE−/− compared withThbs1−/−ApoE−/− mice as analysed by repeated measures
two-way ANOVA (P=0.029, Figure 2C). Heart rate was similar in both groups throughout the study (results not
shown).
Evaluation of total nitrite and nitrate (nitric oxide metabolites) within plasma collected after 28 days of AngII
infusion showed significantly highermedian levels in experimentalThbs1−/−ApoE−/− (59.87μM, IQR: 32.79–70.95)
compared with the control ApoE−/− mice (27.67 μM, IQR: 4.28–36.04, P=0.041; Table 3).
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Table 3 The concentrations of cytokines within the platelet-poor plasma of control ApoE−/− and experimental
Thbs1−/−ApoE−/− mice infused with AngII for 28 days
Samples ApoE−/− (n=8) Thbs1−/−ApoE−/− (n=8) P-value
MCP-1 (pg/ml) 8.52 (6.22–18.61) 47.56 (11.26–77.43) 0.026
IL-6 (pg/ml) 38.86 (17.31–76.94) 250 (44.30–372.80) 0.041
IL-10 (pg/ml) 65.61 (43.83–230.70) 225.30 (58.50–408.10) 0.227
IFN-γ (pg/ml) 74.16 (55.08–200.50) 184.50 (71.01–275.10) 0.278
TNF (pg/ml) 252.50 (42.01–394) 560.30 (346.60–658) 0.063
IL-12p70 (pg/ml) 43.76 (7.28–68.72) 88.77 (19.11–193.50) 0.228
NOx metabolites (nM) 27.67 (4.28–36.04) 59.87 (32.79–70.95) 0.041
Total TGF-β1 (ng/ml) 3.61 +− 0.21 3.74 +− 0.90 0.589
Active TGF-β1 (ng/ml) 0.50 +− 0.04 0.16 +− 0.02 0.001
Concentrations of cytokines (pg/ml) were measured in the platelet-poor plasma (n=8/group) using an inflammatory bead assay. NOx metabolites
were assessed by Griess assay. Total and active TGF-β1 were assessed by an activity assay. Data expressed as median and IQRs are compared
by Mann–Whitney U test. Tgf-β1 data presented as mean +− S.E.M. and analysed by Student’s t test. Statistical significance considered as P-value
<0.05. Abbreviations: mTgf, mouse transforming growth factor; NOx, total nitrite and nitrate metabolites.
AngII induced AAA was associated with increased ECM degradation in
Thbs1−/−ApoE−/− mice
Serial sections of SRA segments were used for morphological assessments by histology. Compared with control
ApoE−/− mice, experimental Thbs1−/−ApoE−/− mice had increased aortic medial thickness, increased inflamma-
tory cell infiltration, more necrotic regions and bigger intramural thrombus (Figure 3A). The presence of red blood
cells and large intramural haematomas was evident in the H&E-stained SRA sections of Thbs1−/−ApoE−/− mice.
EVG staining demonstrated disruption of elastin filaments in both control ApoE−/− and Thbs1−/−ApoE−/−
(Figure 3B) mice. Quantification of elastin breaks in ApoE−/− andThbs1−/−ApoE−/− SRA sections suggested more
severe medial layer disruption in experimental mice. The mean grade (+− S.E.M.) of elastin degradation was signif-
icantly higher in Thbs1−/−ApoE−/− (3.80 +− 0.12) compared with control ApoE−/− mice (2.50 +− 0.46, P= 0.025;
n=8/group; Figure 3E).
Increased numbers of apoptotic cells were observed in sections taken from the SRA of experimental
Thbs1−/−ApoE−/− compared with control ApoE−/− mice (n=6/group) after they had received AngII infusion for
28 days (Figure 3C). TUNEL-positive staining was identified within the intima, adventitia and particularly within the
medial elastic lamellae of the SRA in both the groups. TUNEL-positive staining area was significantly greater within
the SRA of experimental Thbs1−/−ApoE−/− (median TUNEL staining area: 21.50%, IQR: 19.16–23.05) compared
with control ApoE−/− mice (median TUNEL staining area: 11.50%, IQR: 8.61–13.41, P=0.002; Figure 3F).
TSP-1 deficiency enhanced the systemic and aortic inflammatory
response to AngII infusion
Systemic inflammationwas assessed in platelet-poor plasma collected after 28 days of AngII infusion by amultiplexed
flow cytometric assay. Thbs1−/−ApoE−/− mice had higher median plasma concentrations of monocyte chemoat-
tractant protein (MCP)-1 (47.56 pg/ml, IQR: 11.26–77.43 compared with 8.52 pg/ml, IQR: 6.22–18.61; P=0.026) and
IL-6 (250 pg/ml, IQR: 44.30–372.80 compared with 38.86 pg/ml, IQR: 17.31–76.94; P=0.041) compared with con-
trol ApoE−/− mice. A similar but non-significant trend was observed for plasma concentrations of IL-10, IL-12p70,
IFN-γ and TNF-α (Table 3).
Macrophage infiltration as identified by CD68 staining was observed in sections taken from the SRA of both exper-
imental Thbs1−/−ApoE−/− and control ApoE−/− mice (n=6/group) after they had received AngII infusion for 28
days (Figure 3D).MarkedCD68 stainingwas identified within the adventitia and particularly within the tunicamedia
of the SRA inThbs1−/−ApoE−/− mice (Figure 3D). ThemedianCD68-positive staining area was significantly greater
within the SRA of experimental Thbs1−/−ApoE−/− (29.27%, IQR: 22.50–37.50) compared with control ApoE−/−
mice (20.80%, IQR: 15.01–24.81, P=0.041; Figure 3G).
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Figure 3. Histological features of AngII infused AAA in Thbs1−/−ApoE−/− mice
(A) Representative light microscope images of H&E staining showing medial and intimal inflammatory cell infiltration in ApoE−/− and
Thbs1−/−ApoE−/− mice infused with AngII for 28 days. Increased medial thickening and intramural inflammatory cell infiltration was noted
in the SRA of Thbs1−/−ApoE−/− mice. Original magnification ×400. Scale bars =50 μm. (B) Representative EVG staining (black after stain-
ing with EVG) showing greater focal elastin breaks along with marked neointima formation in Thbs1−/−ApoE−/− mice compared with the
control ApoE−/−. Scale bars =50 μm. (C) Representative photomicrograph showing that TSP-1 deficiency promotes apoptosis. Detec-
tion of apoptosis was performed by TUNEL assay using the VasoTACS in situ apoptosis detection kit in SRA sections of ApoE−/− and
Thbs1−/−ApoE−/− mice infused with AngII for 28 days. Representative TUNEL staining showing increased presence of apoptotic and disin-
tegrated cells in Thbs1−/−ApoE−/− mice infused with AngII. Original magnification×400. Scale bars=50 μm. (D) Representative microscopy
images of macrophage staining using rat anti-mouse CD68 antibody in AngII-infused ApoE−/− and Thbs1−/−ApoE−/− mice. (E) Quantifi-
cation of elastin breaks in ApoE−/− and Thbs1−/−ApoE−/− mice within SRA sections. Elastin breaks were quantified based on previously
published criteria (see ‘Materials and methods’ section). The numbers of elastin breaks were higher in Thbs1−/−ApoE−/− compared with
control ApoE−/− mice. Results are mean +− S.E.M. elastin degradation grade. Statistical analysis by Fisher’s exact tests for n=8/group.
(F) Quantification graph of TUNEL staining in SRA sections of ApoE−/− and Thbs1−/−ApoE−/− mice. Shown is data expressed as median
and IQR with maximum and minimum data points (whiskers) for positive staining area relative to total specimen area (%) and compared
by Mann–Whitney U test (n=6/group). (G) Quantificative analysis of macrophage infiltration within the SRA specimens was performed by
evaluating the area of CD68-positive staining in non-necrotic areas. The results are presented as a percentage of CD68-positive staining
area in sections from AngII infused ApoE−/− compared with Thbs1−/−ApoE−/− mice. Data expressed as median and IQR with maximum
and minimum data points (whiskers) and compared by Mann–Whitney U test (n=6/group).
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Table 4 Relative expression of genes within the SRA of control ApoE−/− and experimental Thbs1−/−ApoE−/− mice infused
with AngII for 28 days
Genes Sample Genotype Median expression (IQR) P-value
Mmp-9 SRA (n=6) ApoE−/− 0.29 (0.11–0.63) 0.026
Thbs1−/−ApoE−/− 0.97 (0.70–1.27)
Col1A1 SRA (n=6) ApoE−/− 1.95 (1.56–4.37) 0.041
Thbs1−/−ApoE−/− 1.47 (1.14–1.77)
VSMC (n=6) ApoE−/− 0.70 (0.20–3.08) 0.787
Thbs1−/−ApoE−/− 0.51 (0.32–0.72)
Col3A1 SRA (n=6) ApoE−/− 2.21 (1.35–6.50) 0.015
Thbs1−/−ApoE−/− 0.30 (0.04–1.45)
VSMC (n=6) ApoE−/− 2.78 (1.15–3.76) 0.015
Thbs1−/−ApoE−/− 0.17 (0.10–1.25)
Lrp1 SRA (n=6) ApoE−/− 2.66 (1.99–5.13) 0.015
Thbs1−/−ApoE−/− 1.02 (0.55–1.74)
VSMC (n=6) ApoE−/− 1.03 (0.32–1.92) 0.041
Thbs1−/−ApoE−/− 0.25 (0.17–0.47)
Data expressed as median and IQRs and compared by Mann–Whitney U test. Statistical significance considered as P-value <0.05. Abbreviations: LRP,
low-density receptor related protein; n, number of mice.
Plasma concentrations of active TGF-β1 were lower in Thbs1−/−ApoE−/−
mice than control mice but markers of TGF-β1 signalling were not
different in aortic samples from Thbs1−/−ApoE−/− and control mice
The levels of total and active TGF-β1 were assessed within the platelet-poor plasma from mice collected after 28
days of AngII infusion. Plasma concentrations of total TGF-β1 were similar in ApoE−/− and Thbs1−/−ApoE−/−
mice. Plasma levels of active TGF-β1 were significantly lower inThbs1−/−ApoE−/− compared with ApoE−/− mice
(0.16 +− 0.02 ng/ml compared with 0.50 +− 0.04 ng/ml, P=0.001; Table 3). Analysis of SRA lysates by Western blot-
ting demonstrated that levels of aortic tissue p-Smad2/3 to total-Smad2/3 were not significantly different in the
Thbs1−/−ApoE−/− mice compared with ApoE−/− mice (Supplementary Figure S4). In addition, the level of aortic
tissue p-Akt to total-Akt was also not significantly different in Thbs1−/−ApoE−/− mice compared with ApoE−/−
mice (Supplementary Figure S5).
TSP-1 deficiency enhanced systemic and aortic MMP-9 expression
Prior to AngII infusion, the level of plasma MMP-9 was significantly higher inThbs1−/−ApoE−/− (162.50 +− 14.05
ng/ml) compared with ApoE−/− (75.06 +− 9.32 ng/ml, P<0.001) mice. AngII infusion for 28 days resulted in in-
creased MMP-9 concentrations in the plasma of both the groups with higher mean (+− S.E.M.) levels of MMP-9 in
Thbs1−/−ApoE−/− comparedwith theApoE−/− (210.50+− 27.05 ng/ml comparedwith 121+− 25.20 ng/ml,P=0.030)
mice. Quantitative real-time PCR analysis of mRNA extracted from the SRA of mice infused with AngII for 28 days
showed significantly higher relative expression of Mmp-9 in Thbs1−/−ApoE−/− (median relative gene expression:
0.97, IQR: 0.70–1.27) compared with control ApoE−/− mice (median relative gene expression: 0.29, IQR: 0.11–0.63,
P=0.026, Table 4).
We also assessed gelatinase activity within SRA sections from mice infused with AngII for 28 days using in
situ zymography. The gelatinase activity was marked within the media and adventitia of Thbs1−/−ApoE−/− com-
pared with control ApoE−/− mice (Figure 4A). A semiquantitative analysis of gelatinase activity (% positivity rel-
ative to the whole-section area) was performed in cryostat sections of SRA segments. The median gelatinase ac-
tivities were 30.50% (IQR: 26.34–40.82) and 21.04% (IQR: 15.12–28.07, P=0.041; n=6/group) in experimental
Thbs1−/−ApoE−/− and control ApoE−/− mice respectively (Figure 4B).
TSP-1 deficiency was associated with decreased collagen content and
reduced LRP1 expression within the SRA
The collagen content of SRA sections was analysed by Picrosirius Red staining followed by polarization microscopy
and image analysis. There was significantly less fibrillar collagen within SRA sections taken fromThbs1−/−ApoE−/−
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Figure 4. TSP-1 deficiency aggravates inflammation and promotes matrix degradation in AngII-infused AAA
(A) Representative photomicrograph of in situ zymography showing that absence of TSP-1 induces increased MMP-gelatinase activity
within the SRA. MMP-gelatinase activity is evident as green fluorescence signal and elastin lamellae are stained blue under fluorescent
microscopy. Original magnification ×400. Scale bars =50 μm. The Thbs1−/−ApoE−/− SRA showed marked elevation in the gelatinolytic
area. (B) Semiquantitative analysis (% positivity relative to the whole section) of MMP-gelatinase activity in SRA sections of control ApoE−/−
and experimental Thbs1−/−ApoE−/− mice infused with AngII for 28 days. Elastin lamellae are stained blue. Data expressed as median and
IQR with maximum and minimum data points (whiskers) and compared by Mann–Whitney U test (n=6/group). (C) Representative bright-field
images of Picrosirius staining in AngII-infused ApoE−/− and Thbs1−/−ApoE−/− mice. (D) Representative polarization microscopy images of
Picrosirius staining in AngII-infusedApoE−/− and Thbs1−/−ApoE−/− mice. Quantitative analysis of collagen deposition in the SRA specimens
was performed by evaluating the polarization birefringence image staining. (E) Quantitative analysis of collagen staining in the SRA sections
was performed by evaluating the percentage of birefringent staining area in the AngII infused ApoE−/− compared with Thbs1−/−ApoE−/−
mice under polarized light. Data expressed as median and IQR with maximum and minimum data points (whiskers) and compared by
Mann–Whitney U test (n=6/group). For all images, original magnification ×400. Scale bars =50 μm. * denotes lumen.
compared with ApoE−/− mice (Figure 4C, D). The collagen content was not evenly distributed but localized in de-
posits in the dilated aneurysmal regions with clear necrotic areas in between suggesting reduced synthesis of new
collagen deposits. Under polarization imaging, the SRA sections of Thbs1−/−ApoE−/− mice showed less collagen
birefringence compared with the SRA sections of ApoE−/− mice (Thbs1−/−ApoE−/− median % birefringence area:
52.24%, IQR: 41.36–58.34 compared withApoE−/− 66.49%; IQR: 58.12–71.45, n=6/group; P=0.022; Figure 4E). We
also assessed the transcript levels of twomajor collagen genes inmRNA isolated fromSRA segments by qRT-PCR. The
median relative Col1A1mRNA expression was lower inThbs1−/−ApoE−/− compared with ApoE−/− mice (median
relative gene expression: 1.47, IQR: 1.14–1.77 compared with 1.95, IQR: 1.56–4.37, P=0.041, Table 4). Similarly, the
median relative Col3A1 mRNA expression was significantly lower in Thbs1−/−ApoE−/− compared with ApoE−/−
mice (median relative gene expression: 0.30, IQR: 0.04–1.45 compared with 2.21, IQR: 1.35–6.50, P=0.015; Table 4).
Since VSMCs are the predominant source of collagen in arteries and to assess the expression of collagen genes in
the early phases of matrix remodelling, we infused ApoE−/− andThbs1−/−ApoE−/− mice (n=6/group) with AngII
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for 14 days and then isolated VSMCs from the SRA segments. The median relative expression of Col1A1 was similar
in the two groups of mice (Table 4). Col3A1 expression was lower in VSMCs isolated fromThbs1−/−ApoE−/− mice
(median relative gene expression: 0.17, IQR: 0.10–1.25 compared with 2.78, IQR: 1.15–3.76, P=0.015) supporting the
altered phenotype of VSMCs in the SRA of Thbs1−/−ApoE−/− mice (Table 4).
TSP-1 binds to LRP1 to signal changes in cell adhesion and motility [55,56]. LRP1 has also been implicated in
maintaining normal aortic structure since deficiency is associated with spontaneous aneurysm formation in mice
[57].We infused 3-month-oldmaleApoE−/− mice with saline (n=3) and AngII (n=3) for 28 days to assess the effect
of AngII on expression of LRP1. Confocal microscopy suggested that the expression of LRP1 protein within the SRA
was up-regulated after 28-day infusion of AngII (Figure 5A). LRP1 protein expression was mainly localized within
the media with diffuse expression throughout the adventitia. Given the link between LRP1 and TSP-1, we examined
the relative gene expression of Lrp1 in SRA segments obtained fromThbs1−/−ApoE−/− and ApoE−/− mice after 28
days AngII infusion. The relative expression of Lrp1 was significantly lower inThbs1−/−ApoE−/− (median relative
gene expression: 1.02, IQR: 0.55–1.74) compared with ApoE−/− mice (median relative gene expression: 2.66, IQR
1.99–5.13, P=0.015, Table 4, Figure 5B). We also compared the expression of Lrp1 transcripts in VSMCs isolated
from SRA segments of mice infused with AngII for 14 days. The relative expression of Lrp1 was significantly lower
in VSMCs isolated fromThbs1−/−ApoE−/− (median relative gene expression: 0.25, IQR: 0.17–0.47) compared with
ApoE−/− mice (median relative gene expression: 1.03, IQR: 0.32–1.92, P=0.041, Figure 5C).
Discussion
The main findings of the present study were that higher circulating concentrations of TSP-1 were associated with
slower AAA growth in patients, and that within a mouse model, TSP-1 deficiency promoted larger AAAs. AAA
patients with serum concentrations in the highest quartile were less likely to have AAA growth greater than median.
This observation is in accordance with our previous report that serum TSP-1 was negatively associated with AAA
diagnosis inmen after adjusting for other risk factors [23]. This previous proteomic analysis of intraluminal thrombus
conducted in our laboratory identified a group of proteins, including TSP-1, to be concentrated in AAA thrombus
suggesting this may lead to lower circulating levels of these proteins [23]. A recent study reported that AAA tissues
showed higher TSP-1 expression levels by IHC compared with organ donor aortic wall samples [26]. However, in
our current study, IHC results suggested that TSP-1 was sparsely expressed within the main body of the wall of the
AAA compared with the higher expression levels in relatively disease-free AAA neck. Given the relative deficiency of
TSP-1 within the AAAwall and plasma in patients, we examined the effect of TSP-1 deficiency in a mouse model.We
found that deficiency of Thbs1 in ApoE−/− mice resulted in larger AAAs and increased atherosclerosis in response
to AngII infusion.
Deficiency of TSP-1 has been reported to show contrasting effects in different experimental studies [26,28,29,58].
Lack of TSP-1 has been reported to promote inflammatory response to retinal injury and inflammatorymediated lung
injury in C57BL/6mice [28,58]. TSP-1 deficiency has also been reported to promote inflammation within atheroscle-
rotic plaques of ApoE−/− mice [29]. In contrast, TSP-1 deficiency in C57BL/6 mice was reported to limit inflam-
mation and aneurysm formation induced by aortic infusion of elastase or peri-adventitial application of calcium
phosphate [26]. Our findings therefore contrast markedly from those of Liu et al. [26] but are consistent with our
previous work and the findings of other investigators [24]. Our observations are also in accordance with those by
Moura et al. [29], who reported that aortic macrophage infiltration was twice as high in Thbs1−/−ApoE−/− com-
pared with ApoE−/−, which coincided with a 30-fold increase in elastin lamina degradation and accumulation of
MMP-9. Overall, these findings suggest that in the presence of concurrent atherosclerosis, as found inApoE−/− mice
and AAA patients, deficiency of TSP-1 promotes AAA. In the absence of atherosclerosis, TSP-1 is reported to have
pro-aneurysmal effects however given the almost universal presence of atherosclerosis in AAA patients, that situation
would be expected to be less relevant to patients. The findings of Liu and colleagues may be more relevant to human
thoracic aortic aneurysm in which monogenetic mutations often lead to early presentation of disease in the absence
of atherosclerosis [26]. It is interesting to note that we did not find any propensity to thoracic aortic aneurysm in
Thbs1−/−ApoE−/− mice subjected to AngII infusion.
Previous studies have suggested that the elevation of blood pressure during AngII infusion is not causal in
AAA or atherosclerosis progression induced by AngII [54,59,60]. In the present study, both control ApoE−/− and
Thbs1−/−ApoE−/− showed time-dependent increase in SBP during AngII infusion. However, the SBP increase in
Thbs1−/−ApoE−/− mice was less severe than that in ApoE−/− mice. Previous studies suggest that TSP-1 is able to
modulate blood pressure through increasing nitric oxide production [61]. In the current study, we found elevated
nitrate levels in the plasma of AngII-infused Thbs1−/−ApoE−/− mice in comparison with control animals. These
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Figure 5. TSP-1 deficiency alters LRP1 expression in AngII-infused AAA
(A) Representative confocal images showing typical LRP1 staining in Ang-II infused AAA in ApoE−/− mice. The first panel of merged images
shows sections of the SRA from saline-infused control ApoE−/− and AngII-infused ApoE−/− mice. The green staining is phalloidin (actin) and
the red staining is LRP1. The confocal images show enhanced LRP1 expression in the SRA of an AngII-infused ApoE−/− mouse. The merged
images in the first panel is 1417 μm × 1417 μm. The zoomed-in images in the second and third panels are 290 μm × 290 μm. (B) Expression
of the Lrp1 within the SRA of AngII-infused ApoE−/− and Thbs1−/−ApoE−/− mice. Quantitation graphs depict decreased expression of Lrp1
within SRA segments of Thbs1−/−ApoE−/− compared with the control ApoE−/− mice. Data are expressed as median and IQR with maximum
and minimum data points (whiskers) for relative gene expression. Statistical significance calculated with non-parametric Mann–Whitney test
(n=8/group). (C) Expression of the Lrp1 within VSMCs from AngII-infused ApoE−/− and Thbs1−/−ApoE−/− mice. Quantitation graph depicts
decreased expression of Lrp1 within VSMCs isolated from SRA segments of Thbs1−/−ApoE−/− compared with the control ApoE−/− after
AngII infusion for 14 days. Data are expressed as median and IQR with maximum and minimum data points (whiskers) for relative gene
expression. Statistical significance calculated with non-parametric Mann–Whitney test.
results suggest that the deficiency of TSP-1 results in increased nitric oxide bioavailability and less marked SBP rise
in response to AngII infusion. They also agree with previous findings that AAA formation induced by AngII is inde-
pendent of changes in SBP [54].
Inflammation is implicated in AAA [62,63]. Our results suggest that the absence of TSP-1 promotes systemic and
aortic inflammation in response to AngII infusion. This result is in accordance with several previous reports suggest-
ing that TSP-1 inhibits inflammation [29,64–67]. In the current study, active plasma TGF-β1 levels were considerably
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Figure 6. Proposed working model of the protective effect of cell signalling in response to TSP-1 binding to the LRP1
receptor co-complex in the aortic wall
TSP-1 binds to CRT through the N-terminal trimer or the TSP-1 CRT binding peptide (hep I). Binding of TSP-1 to the CRT-LRP1 co-com-
plex leads to the activation of several signalling pathways resulting in: regulation of the inflammatory response, increasing VSMC survival,
preservation of elastin, deposition of fibrillar collagen (Col3A1), regulation of proteolytic activity, resulting in the preservation of the aortic
wall. However, in the absence of TSP-1, the reduced LRP1 expression leads to aberrant up-regulation of these signalling pathways leading
to an increased inflammatory response, especially monocyte infiltration, increased VSMC apoptosis, increased ECM degradation due to
degradation of elastin layers and reduced deposition of Col3A1 and increased matrix degradation due to increased MMP-9 levels. The
dysregulating of the TSP-1-LRP1 signalling pathway results in maladaptive remodelling leading to development and progression of aortic
aneurysm. Abbreviation: CRT, calreticulin.
lower inThbs1−/−ApoE−/− than control mice. Subsequent analysis of downstream Smad2/3 and Akt phosphoryla-
tion suggested however that the TGF-β1 signalling pathway was not activated inThbs1−/−ApoE−/− mice. Thus, our
results suggest that defective TGF-β1 activation is not responsible for the predisposition of Thbs1−/−ApoE−/− mice
for AngII-induced AAA and atherosclerosis. Our findings are similar to a previous report that Thbs1−/−ApoE−/−
and ApoE−/− mice had similar Smad2/3 phosphorylation levels [29].
AngII infusion inmice promotes disruption of elastin fibres, enhanced apoptosis and proteolytic destruction of the
medial ECM [68,69]. We noted higher elastin degradation and enhanced apoptosis inThbs1−/−ApoE−/− mice com-
pared with the controlApoE−/− mice. VSMC loss due to apoptosis is believed to be a crucial step in AAA progression
[70] and TSP-1 is known to be involved in the clearance of apoptotic neutrophils and eosinophils by macrophages
[71,72]. The increased apoptotic cell numbers observed in the SRA of Thbs1−/−ApoE−/− mice could be due to the
defective clearance of apoptotic cells rather than an increased apoptosis per se.
MMP-9 has been implicated in AAA formation, progression and rupture [73]. In the current study, deficiency of
TSP-1was associatedwith amarked increase inMMP-9 expression and gelatinase activity within the SRA. The level of
plasmaMMP-9 was higher inThbs1−/−ApoE−/− than control mice both prior to and after AngII infusion. This is in
accordance with a previous report in a mouse model of dermal wound healing inThbs1−/− mice in which increased
levels of matrix proteolysis enzymes and aberrant ECM remodelling were reported [74,75]. TSP-1 was also reported
to attenuate gelatinase activity through its carboxy-terminal fragment [76] by up-regulating tissue inhibitor of MMP
(TIMP)-2 (TIMP-2) expression and inhibiting the activity of MMP-9 [77]. Since macrophages are important sources
of MMPs, the marked accumulation of macrophages inThbs1−/−ApoE−/− mice may have promoted the increased
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systemic and aortic MMP production [78]. Taken together, our observations are in accordance with previous reports
suggesting that enhanced matrix degradation due to elevated MMP-9 occurs in the absence of TSP-1.
The fibrillar collagen network,mainly type III collagen, provides tensile strength to the aortic wall. Previous studies
suggest that collagen turnover is ineffective in AAA patients [79–86]. It is postulated that as AAA progresses, the syn-
thesis and structure of collagen is insufficient to counteract increasedmechanical wall stress and as a consequence the
AAA expands and ruptures [82]. We found reduced Col3A1 expression in VSMC isolated fromThbs1−/−ApoE−/−
mice suggesting that TSP-1 deficiency influenced the response of VSMCs to AngII. This may have played a role in the
ability of the aorta to withstand inflammation and proteolysis induced by AngII infusion. Despite this, Thbs1 defi-
ciency was not associatedwith increased incidence of AAA rupture, although our studymay have not been adequately
powered to test this.
LRP1 is a large endocytic receptor that belongs to the LDLR family. A critical role for LRP1 was recently reported
to be maintaining the integrity of vessels by regulating protease activity as well as ECM deposition [87]. Reduced
LRP1 expression in the aneurysmal wall is reported to be due to the increased shedding of the LRP1 ectodomain as
a consequence of heightened inflammation and MMP activity [88]. A genetic polymorphism in LRP has been asso-
ciated with AAA and within a mouse model deficiency of LRP1 has been associated with aortic aneurysm formation
[87,89,90]. Our observation in ApoE−/− mice suggests that AngII infusion leads to LRP1 up-regulation and in the
absence of TSP-1, LRP1 expression is down-regulated. Furthermore, our recent study showed that LRP1 expression
was lower in AAA patient biopsies compared with controls, and that in vitro blockade of LRP1 significantly reduced
the ability of VSMCs to clear MMP-9 [91]. These findings suggest that TSP-1 deficiency might promote AAA by the
associated down-regulation of LRP1 and Col3A1 and up-regulation of MMP-9 (Figure 6).
The present study has a number of limitations. The clinical findings in the present study are restricted to men
and have unknown relation to AAAs in women [92]. Another limitation of the present study is that we used only
one mouse model of AAA, although previous studies have been performed in other models which do not typically
incorporate atherosclerosis. The results could have also been strengthened by including experiments to investigate if
TSP-1 administration corrected the AAA propensity of Thbs1−/−ApoE−/− mice.
In conclusion, the present study suggests AAA growth is promoted by TSP-1 deficiency. Based on our findings
and that of other investigators, it seems likely that the effects of TSP-1 are context dependent and our experimental
findings may be particularly relevant to aortic aneurysms formed in association with atherosclerosis. Our findings
suggest the importance of TSP-1 as a matrix protein protecting the integrity of the aortic ECM.
Clinical perspectives
• The role of TSP-1 in aortic aneurysm is conflicting.
• Circulating TSP-1 levels were negatively correlated with aortic aneurysm growth and men with
TSP-1 in the highest quartile had a reduced likelihood of aortic aneurysm growth.
• Knockout of the TSP-1 gene in ApoE−/− mice and induction of aortic aneurysm using AngII
infusion generated larger aneurysms, which were also associated with greater inflammation, in-
creased apoptosis and increased ECM degradation.
• These clinical and preclinical observations are novel and suggest potential important implications
for treating AAA.
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